Overview

Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study

Status:
ENROLLING_BY_INVITATION
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
Study population: Type 2 diabetes patients Design of the study: Randomized, two-arm, placebo-controlled, and prospective crossover cohort study. Objective: To evaluate the effects of interactions between metformin and traditionally used polyherbal formulations on gut microbiota in a prospective crossover study involving type 2 diabetes mellitus patients. Sample size: 66 patients. Duration of study: 06/2024 - 12/2026
Phase:
NA
Details
Lead Sponsor:
Pauls Stradins Clinical University Hospital
Treatments:
Metformin